drugset
drugset / Trial / NCT00717288

Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir

NCT00717288 ↗

Phase 4 Completed 82 enrolled Ohio State University Novo Nordisk A/S · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

In this study we will determine the proper method for transitioning patients from a continuous insulin infusion to periodic injections of a newer long-acting insulin called detemir (Levemir).

Timeline

Start
2008-07
Primary completion
2010-03
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator insulin detemir Protein / enzyme biologic 50 % Subcutaneous
Comparator insulin detemir Protein / enzyme biologic 65 % Subcutaneous
Comparator insulin detemir Protein / enzyme biologic 80 % Subcutaneous

Indications

diabetes mellitus